HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Core Assets of Southward Funds

1,123.620

-2.229-0.20%

Number of Gainers:21

Number of Losers:40

Number of Flat:6

PE:- -

High:1,130.772

Open:1,125.841

Low:1,108.835

Close:1,125.849

Loading ...

Hansoh Pharmaceutical - Units Entered Into a License Agreement With Regeneron Pharmaceuticals

THOMSON REUTERS

Hansoh Pharmaceutical - Licensors Shall Grant an Exclusive Worldwide License to Develop, Manufacture and Commercialize Hs-20094

THOMSON REUTERS

Regeneron Secures Global Rights to Novel GLP-1/GIP Receptor Agonist, Expanding Obesity Treatment Portfolio with Strategic In-Licensing from Hansoh Pharmaceuticals

Shandong Weigao Group Medical Polymer Co. Ltd. Completes Buyback of 307,600 Shares for HKD 1.61M

China Literature to Boost Stake in Animated Series Creator

MT Newswires Live

BRIEF-Tencent Bought Back 1 Million Shares On June 2- HKEX Filing

Zeekr Group Reports 15.2% Year-Over-Year Growth with 46,538 Vehicles Delivered in May 2025

S&P Revises Outlooks on Geely Automobile Holdings, Parent to Negative on Profitability Strain

MT Newswires Live

Topgolf Callaway Brands Completes Sale of Jack Wolfskin to ANTA Sports for $290 Million

ANTA Sports Announces Management Changes: Jiang Yan Joins Sustainability Committee

BREAKINGVIEWS-Wanda lights up China's great property firesale

Market Chatter: Country Garden's Offshore Debt Restructuring Stalls

MT Newswires Live

Innovent Biologics Presents Promising Phase 1 Results for IBI363 in Advanced Colorectal Cancer at 2025 ASCO Meeting

2025 Asco Oral Presentation: Innovent Biologics Announces Updated Date of Ibi363 (First-in-Class Pd-1/Il-2Α-Bias Bispecific Antibody Fusion Protein) From Phase 1 Clinical Studies in Advanced Colorectal Cancer

THOMSON REUTERS

BRIEF-Xiaomi delivers Over 28,000 EVs in May

China's Xiaomi: Domestic Electric Vehicle Deliveries Exceeded 28,000 Units in May

THOMSON REUTERS

Innovent Biologics Announces Groundbreaking Phase 2 Trial of IBI363 for Treatment-Resistant Melanoma at ASCO 2025

Asco 2025 Oral Presentation: Innovent Biologics Announces Updated Data of Ibi363 (First-in-Class Pd-1/Il-2Α -Bias Bispecific Antibody Fusion Protein) From Phase 1 and 2 Clinical Studies on Immunotherapy-Treated Advanced Malignant Melanoma

THOMSON REUTERS

Zeekr Group Reports 15.2% Year-Over-Year Growth with Over 46,000 Vehicles Delivered in May 2025

BRIEF-Hansoh Pharmaceutical Says Third Biologics License Application Of Xinyue (Inebilizumab Injection) Accepted By NMPA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1589/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1589","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1589\",,,,,undefined,":{"symbol":"BK1589","market":"HK","secType":"PLATE","nameCN":"Core Assets of Southward Funds","latestPrice":1123.62,"timestamp":1749197315293,"preClose":1125.8485,"halted":0,"volume":1909162160,"delay":0,"changeRate":-0.001979,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-2.228516,"latestTime":"06-06 16:00:00","open":1125.8408,"high":1130.7719,"low":1108.8348,"amount":50411219924.9,"amplitude":0.019485,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749432600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1749173400000,1749182400000],[1749186000000,1749196800000]],"pbRate":2.106,"peRate":17.544731,"turnoverRate":0.003411,"increases":20,"decrements":44,"flats":3,"marketCap":15678420809216,"floatMarketCap":14660641200640},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1589\",,,,,undefined,":{"symbol":"BK1589","high":1130.7719,"amplitude":0.019485,"preClose":1125.8485,"low":1108.8348,"pbRate":"2.106","latestPrice":1123.62,"volume":1909162160,"delay":0,"open":1125.8408,"prevYearClose":949.2231,"prevWeekClose":1095.019,"prevMonthClose":1095.019,"prevQuarterClose":1071.805,"fiveDayClose":1095.019,"twentyDayClose":1067.642,"sixtyDayClose":1138.122,"secType":"PLATE","market":"HK","turnoverRate":0.003411,"peRate":17.544731,"marketCap":15678420809216,"floatMarketCap":14660641200640,"timestamp":1749197315293,"nameCN":"Core Assets of Southward Funds"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1589\",,,,undefined,":{"bkCode":"BK1589","up":21,"down":40,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1589\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540678037","title":"Hansoh Pharmaceutical - Units Entered Into a License Agreement With Regeneron Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2540678037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540678037?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:07","pubTimestamp":1748862428,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S3022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","BK1191","03692","BK1583"],"gpt_icon":0},{"id":"2540476782","title":"Hansoh Pharmaceutical - Licensors Shall Grant an Exclusive Worldwide License to Develop, Manufacture and Commercialize Hs-20094","url":"https://stock-news.laohu8.com/highlight/detail?id=2540476782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540476782?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:07","pubTimestamp":1748862428,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S3022:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03692","BK1583","BK1191","BK1589"],"gpt_icon":0},{"id":"2540676789","title":"Regeneron Secures Global Rights to Novel GLP-1/GIP Receptor Agonist, Expanding Obesity Treatment Portfolio with Strategic In-Licensing from Hansoh Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2540676789","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540676789?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:06","pubTimestamp":1748862360,"startTime":"0","endTime":"0","summary":"Regeneron Secures Global Rights to Novel GLP-1/GIP Receptor Agonist, Expanding Obesity Treatment Portfolio with Strategic In-Licensing from Hansoh Pharmaceuticals. Regeneron Pharmaceuticals, Inc. has announced a strategic in-licensing agreement with Hansoh Pharmaceuticals Group Company Limited to acquire exclusive clinical development and commercial rights for a dual GLP-1/GIP receptor agonist, HS-20094, outside of the Chinese Mainland, Hong Kong, and Macau. Currently in Phase 3 testing, this therapeutic candidate has been studied in over 1,000 patients as a weekly subcutaneous injection, showing promising efficacy and safety data. The agreement includes an upfront payment of $80 million to Hansoh, with potential additional payments up to $1.93 billion based on achievement of development, regulatory, and sales milestones. Regeneron aims to integrate this candidate into its portfolio to address muscle loss and other obesity-related comorbidities.Disclaimer: This news brief was created b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL7VzY3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0058720904.USD","IE00BKPKM429.USD","LU2362541513.USD","LU1974910355.USD","BK1583","LU0882574055.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","BK1589","LU2468319806.SGD","LU0320765992.SGD","BK4112","BK4585","LU0053666078.USD","LU2095319765.USD","LU2237438978.USD","LU0823416689.USD","LU0889565916.HKD","LU2362540622.SGD","NDAQ","LU0114720955.EUR","BK1191","LU1917777945.USD","LU2362541273.HKD","REGN","LU0289739699.SGD","IE00BGHQF748.EUR","LU0823434583.USD","LU0109394709.USD","LU2023250504.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","LU0823434740.USD","03692","LU2106854487.HKD","LU2089984988.USD","BK4588"],"gpt_icon":0},{"id":"2540762543","title":"Shandong Weigao Group Medical Polymer Co. Ltd. Completes Buyback of 307,600 Shares for HKD 1.61M","url":"https://stock-news.laohu8.com/highlight/detail?id=2540762543","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540762543?lang=en_us&edition=fundamental","pubTime":"2025-06-02 18:40","pubTimestamp":1748860805,"startTime":"0","endTime":"0","summary":"Shandong Weigao Group Medical Polymer Co. Ltd. has conducted a buyback transaction involving 307,600 units for holding as treasury shares. The aggregate price paid for the repurchased units was approximately HKD 1,614,848, with a repurchase price of HKD 5.25 per unit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. published the original content used to generate this news brief on June 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDLc7GBlG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","01066","BK1222","LU0173614495.USD","LU0287142896.SGD"],"gpt_icon":0},{"id":"2540762898","title":"China Literature to Boost Stake in Animated Series Creator","url":"https://stock-news.laohu8.com/highlight/detail?id=2540762898","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540762898?lang=en_us&edition=fundamental","pubTime":"2025-06-02 18:31","pubTimestamp":1748860301,"startTime":"0","endTime":"0","summary":"China Literature's  China operating entity Shanghai Hongwen Networking Technology agreed to acquire a 26.67% stake in Wuhan YHKT Entertainment for 324.8 million yuan, according to a Friday filing with the Hong Kong bourse.Founders Ruan Rui, Dong Xiangbo, Chen Wei, and Wuhan YHKT Entertainment's employee shareholding platform Shanghai Huayihua Management Consulting Partnership Enterprise will offload their 11.89% stake, while Hangzhou Cheers Venture Capital Partnership and Ningbo Cheers Equity Investment Partnership will sell their 14.78% stake, the filing said.Once the sale is completed, China Literature's stake in Wuhan YHKT Entertainment, the owner of the Ling Long animated series, will rise to 31.48% from 5.17%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1516","BK1130","BK1589","00772"],"gpt_icon":0},{"id":"2540176411","title":"BRIEF-Tencent Bought Back 1 Million Shares On June 2- HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2540176411","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540176411?lang=en_us&edition=fundamental","pubTime":"2025-06-02 18:18","pubTimestamp":1748859530,"startTime":"0","endTime":"0","summary":"BRIEF-Tencent Bought Back 1 Million Shares On June 2- HKEX FilingJune 2 (Reuters) - TENCENT BOUGHT BACK 1 MILLION SHARES FOR HK$500.5 MILLION ON JUNE 2- HKEX FILINGFurther company coverage: 0700.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S30D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0577902298.EUR","LU2039709279.SGD","IE00B031J352.USD","LU0348805143.USD","LU0634319403.HKD","IE00B8L5B284.USD","LU1188198961.HKD","LU1048596156.SGD","LU0049112450.USD","LU1725190679.HKD","TCHmain","LU2462611646.USD","LU1282649810.SGD","LU1808992512.USD","SG9999014674.SGD","00700","LU1719994722.HKD","LU0228659784.USD","LU1316542783.SGD","IE00B543WZ88.USD","LU0164865239.USD","LU0348827113.USD","LU2476274720.SGD","IE00B8HQ1Z84.USD","LU1152091168.USD","LU0516422440.USD","LU0054237671.USD","LU2265009873.SGD","BK1589","LU0029875118.USD","LU2362541273.HKD","LU0589944569.HKD","LU0823413587.USD","LU0608807433.USD","LU0143863198.USD","HTCD.SI","LU2097828631.EUR","LU2449936058.SGD","LU0633140560.USD","SG9999014880.SGD","LU0862451753.SGD","LU0173614495.USD","SG9999018857.SGD","BK1521","SG9999000459.SGD","LU2097828805.USD","LU0708995583.HKD","LU1366334651.USD","SG9999000327.SGD","IE00B067MR52.USD"],"gpt_icon":0},{"id":"2540764638","title":"Zeekr Group Reports 15.2% Year-Over-Year Growth with 46,538 Vehicles Delivered in May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540764638","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540764638?lang=en_us&edition=fundamental","pubTime":"2025-06-02 18:07","pubTimestamp":1748858829,"startTime":"0","endTime":"0","summary":"Zeekr Intelligent Technology Holding Ltd. has reported its delivery results for May 2025, showcasing a significant growth in vehicle deliveries. The company, recognized as a leading premium new energy vehicle group, delivered a total of 46,538 vehicles across its Zeekr and Lynk & Co brands. This performance marks a 15.2% increase year-over-year and a 12.6% rise compared to the previous month. Specifically, the Zeekr brand delivered 18,908 vehicles, while Lynk & Co contributed with 27,630 vehicles. The company's success is attributed to the support of nearly 1.95 million users.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zeekr Intelligent Technology Holding Ltd. published the original content used to generate this news brief via EDGA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDLYWGNx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zeekr Group Reports 15.2% Year-Over-Year Growth with 46,538 Vehicles Delivered in May 2025","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861214812.USD","80175","LU0315179316.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","GELYY","LU1282651048.USD","EVS.SI","LU0293314216.USD","IE00B0JY6N72.USD","ZK","BK4099","BK1539","IE00BZ08YR35.GBP","LU1282651121.HKD","BK1521","LU1224444064.USD","BK1589","LU2360107325.USD","SG9999002828.SGD","BK1119","LU1861219969.SGD"],"gpt_icon":1},{"id":"2540111761","title":"S&P Revises Outlooks on Geely Automobile Holdings, Parent to Negative on Profitability Strain","url":"https://stock-news.laohu8.com/highlight/detail?id=2540111761","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540111761?lang=en_us&edition=fundamental","pubTime":"2025-06-02 17:41","pubTimestamp":1748857261,"startTime":"0","endTime":"0","summary":"S&P Global Ratings revised its outlooks on Zhejiang Geely Holding Group and subsidiary Geely Automobile Holdings (HKG:0175) to negative from stable, citing mounting pressure on profitability over the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00175","80175","LU1282651121.HKD","LU2360107325.USD","LU1861214812.USD","IE00BZ08YR35.GBP","IE00B0JY6N72.USD","GELYY","LU0293314216.USD","BK1521","LU1861219969.SGD","LU0315179316.USD","EVS.SI","BK1589","BK1119","LU1282651048.USD","IE00BZ08YS42.EUR","SG9999002828.SGD","IE00BZ08YT58.USD","LU1224444064.USD","BK1539"],"gpt_icon":1},{"id":"2540616497","title":"Topgolf Callaway Brands Completes Sale of Jack Wolfskin to ANTA Sports for $290 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2540616497","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540616497?lang=en_us&edition=fundamental","pubTime":"2025-06-02 17:31","pubTimestamp":1748856679,"startTime":"0","endTime":"0","summary":"Topgolf Callaway Brands Corp. has announced the successful completion of the sale of its Jack Wolfskin business to ANTA Sports for $290 million, with the deal closing effectively on May 31, 2025. This transaction marks a significant milestone for Topgolf Callaway Brands as it shifts its strategic focus towards core businesses and bolsters its financial flexibility in anticipation of the planned separation of Topgolf from its main operations. Chip Brewer, President and CEO of Topgolf Callaway Brands, expressed excitement about the development and conveyed confidence in ANTA Sports' ability to uphold the Jack Wolfskin brand's integrity and reputation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TopGolf Callaway Brands Corp. published ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL2f9kFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","LU1188198961.HKD","LU0261950470.USD","LU0463099449.HKD","BK1512","IE00B031HY20.USD","LU0320764599.SGD","BK1168","LU0708995583.HKD","LU0326950275.SGD","BK1227","LU0048575426.USD","LU0251143458.SGD","LU0052750758.USD","IE00BQXX3C00.GBP","LU2008162690.USD","ANPDY","IE0008369823.USD","LU0605514214.HKD","LU2177674079.SGD","IE00B031J352.USD","LU0594300419.USD","BK1502","BK1521","02020","IE00BGV7N243.SGD","BK1500","LU0048597586.USD","LU0251144936.SGD","IE00BQXX3F31.USD","MODG","LU0594300179.USD","BK1589","LU2039709279.SGD","LU0650527681.SGD","IE0008368742.USD","LU0140636845.USD","IE0031814852.USD","LU0261947096.USD","LU0244354667.USD","LU1831875114.USD","82020","BK4190","LU2488822045.USD"],"gpt_icon":0},{"id":"2540761329","title":"ANTA Sports Announces Management Changes: Jiang Yan Joins Sustainability Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2540761329","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540761329?lang=en_us&edition=fundamental","pubTime":"2025-06-02 17:23","pubTimestamp":1748856203,"startTime":"0","endTime":"0","summary":"ANTA Sports Products Limited has announced changes in the composition of its Sustainability Committee. Mr. Yiu Wai Hung, the former CEO of the Fashion Sports Group, will step down from the committee. Ms. Jiang Yan, the current CEO of the Fashion Sports Group, will join the committee. These changes will be effective from June 15, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ANTA Sports Products Limited published the original content used to generate this news brief on June 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL9DSwFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1188198961.HKD","LU0244354667.USD","BK1227","LU0650527681.SGD","ANPDY","BK1502","LU2488822045.USD","LU0140636845.USD","LU0261950470.USD","LU0594300419.USD","LU1831875114.USD","IE0008368742.USD","LU2039709279.SGD","IE00BGV7N243.SGD","LU0251144936.SGD","82020","LU0326950275.SGD","IE0008369823.USD","LU2177674079.SGD","LU0594300179.USD","BK1500","IE00BQXX3C00.GBP","BK1168","IE00BQXX3F31.USD","LU0052750758.USD","02020","IE00B031HY20.USD","IE00BQXX3D17.EUR","LU0261947096.USD","LU0463099449.HKD","BK1512","BK1521","IE00B031J352.USD","LU0605514214.HKD","LU0320764599.SGD","LU0251143458.SGD","LU2008162690.USD","LU0048575426.USD","IE0031814852.USD","LU0048597586.USD","BK1589","LU0708995583.HKD"],"gpt_icon":0},{"id":"2540754943","title":"BREAKINGVIEWS-Wanda lights up China's great property firesale","url":"https://stock-news.laohu8.com/highlight/detail?id=2540754943","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540754943?lang=en_us&edition=fundamental","pubTime":"2025-06-02 11:52","pubTimestamp":1748836370,"startTime":"0","endTime":"0","summary":"BREAKINGVIEWS-Wanda lights up China's great property firesaleThe author is a Reuters Breakingviews columnist. The opinions expressed are his own.By Ka Sing ChanHONG KONG, June 2 (Reuters Breakingviews","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nL3N3RZ06Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4209","LU2237443549.SGD","TCHmain","LU1719994722.HKD","BK1591","89618","LU0315179316.USD","LU0047713382.USD","SBUX","LU0314109678.HKD","LU0348816934.USD","LU0541502299.USD","LU0054450605.USD","LU0642271901.SGD","LU2293587155.HKD","LU0543330483.HKD","BK1526","LU1044874839.SGD","LU0052750758.USD","LU1366334651.USD","LU0029875118.USD","IE0008369823.USD","LU0890818403.SGD","LU1951186391.HKD","LU2476274308.USD","06963","LU1048588211.SGD","LU2177674079.SGD","LU0708995583.HKD","SGXZ90724238.SGD","IE00BGV7N243.SGD","LU2045819591.USD","LU0823397285.USD","LU0828238088.HKD","BK1502","LU0181495838.USD","LU1831875114.USD","LU0594300179.USD","BK1589","LU0320764599.SGD","SG9999014674.SGD","LU0049853897.USD","BK1517","SG9999001846.SGD","HTCD.SI","LU1770034418.SGD","LU1734074674.USD"],"gpt_icon":1},{"id":"2540751276","title":"Market Chatter: Country Garden's Offshore Debt Restructuring Stalls","url":"https://stock-news.laohu8.com/highlight/detail?id=2540751276","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540751276?lang=en_us&edition=fundamental","pubTime":"2025-06-02 11:14","pubTimestamp":1748834044,"startTime":"0","endTime":"0","summary":"Country Garden  bondholders objected to a $178 million compensation deal with a bank syndicate, hindering the builder's efforts to restructure its debt, YiCai Global reported May 30, citing a report from The Paper.The ad hoc group argues the arrangement favors lenders like Bank of China, which hold 48% of the builder's syndicated loans, and unfairly prioritizes them with collateral, according to the report.The group also said the cash payout would drain offshore reserves, hurting US dollar bondholders, YiCai Global wrote.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1555","BK1521","BK1507","BK1589","BK1240","BK1610","02007"],"gpt_icon":0},{"id":"2540753909","title":"Innovent Biologics Presents Promising Phase 1 Results for IBI363 in Advanced Colorectal Cancer at 2025 ASCO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540753909","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540753909?lang=en_us&edition=fundamental","pubTime":"2025-06-02 08:00","pubTimestamp":1748822424,"startTime":"0","endTime":"0","summary":"Innovent Biologics, Inc. has announced promising results from its Phase 1 studies evaluating IBI363, a first-in-class PD-1/IL-2α-bias bispecific antibody fusion protein, in patients with advanced colorectal cancer. The data, presented at the 2025 American Society of Clinical Oncology  Annual Meeting, indicate that IBI363, both as monotherapy and in combination with bevacizumab, shows encouraging responses and overall survival benefits. These findings are particularly noteworthy given colorectal cancer's reputation as an immunologically 'cold' tumor. The studies, conducted in China, the United States, and Australia, underscore IBI363's potential to convert 'cold tumors' into 'hot tumors,' suggesting significant promise for broader clinical development and potential new treatment avenues in immunotherapy-resistant and cold tumor indications.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL1f2vDz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK1583","BK1161","BK1147","01801","LU2328871848.SGD","BK1589","01911","LU2488822045.USD"],"gpt_icon":0},{"id":"2540753935","title":"2025 Asco Oral Presentation: Innovent Biologics Announces Updated Date of Ibi363 (First-in-Class Pd-1/Il-2Α-Bias Bispecific Antibody Fusion Protein) From Phase 1 Clinical Studies in Advanced Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2540753935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540753935?lang=en_us&edition=fundamental","pubTime":"2025-06-02 08:00","pubTimestamp":1748822402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUA1KZZ4T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","LU1969619763.USD","BK1161","BK1589","LU2328871848.SGD","BK1583","01801"],"gpt_icon":0},{"id":"2540780022","title":"BRIEF-Xiaomi delivers Over 28,000 EVs in May","url":"https://stock-news.laohu8.com/highlight/detail?id=2540780022","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540780022?lang=en_us&edition=fundamental","pubTime":"2025-06-01 10:00","pubTimestamp":1748743258,"startTime":"0","endTime":"0","summary":"BRIEF-Xiaomi delivers Over 28,000 EVs in MayJune 1 (Reuters) - Xiaomi Corp 1810.HK:CHINA'S XIAOMI: DOMESTIC ELECTRIC VEHICLE DELIVERIES EXCEEDED 28,000 UNITS IN MAYSource textFurther company coverage: 1810.HK (Reporting by Beijing Newsroom) ((Shi.Bu@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1687b1df86c21fd4de9fa60a43a2f7a4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nP8N3RK076:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1813983027.USD","LU2097828631.EUR","SG9999001093.SGD","LU1303224171.USD","LU1880383440.USD","LU0531971595.HKD","LU1328277881.USD","LU1719994722.HKD","BK1589","LU0348814723.USD","LU0348825331.USD","01810","LU0540923850.HKD","LU0588546209.SGD","81810","LU2097828557.USD","MIUmain","SG9999003461.SGD","LU0823397285.USD","LU0456827905.SGD","HXXD.SI","LU2097828805.USD","LU2476274308.USD","LU1770036033.HKD","LU2039709279.SGD","LU2097828474.EUR","LU1105468828.SGD","LU0417516738.SGD","LU0039217434.USD","LU0823397103.USD","BK1502","SG9999002463.SGD","XIACY","LU0359202008.SGD","LU2476274720.SGD","LU0211977185.USD","LU0327786744.USD","LU1282648689.USD","LU0700851271.USD","LU1720050803.USD","LU1481107354.HKD","LU0348827113.USD","LU1880383366.USD","BK1618","LU1808992512.USD","LU0797268264.HKD","LU1868837565.USD","LU1868838027.USD","LU1956131251.USD","LU2097828714.EUR"],"gpt_icon":0},{"id":"2540800647","title":"China's Xiaomi: Domestic Electric Vehicle Deliveries Exceeded 28,000 Units in May","url":"https://stock-news.laohu8.com/highlight/detail?id=2540800647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540800647?lang=en_us&edition=fundamental","pubTime":"2025-06-01 10:00","pubTimestamp":1748743256,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1687b1df86c21fd4de9fa60a43a2f7a4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nP8N3RK076:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1575","BK1523","LU1023057109.AUD","BK1502","LU0307460666.USD","BK1521","LU0531971595.HKD","LU1328277881.USD","LU1808992512.USD","LU1770034418.SGD","HXXD.SI","LU0823039010.USD","LU0039217434.USD","IE0032431581.USD","LU0918141705.HKD","LU1481107354.HKD","LU0540923850.HKD","LU0314109678.HKD","LU0320764599.SGD","LU0359202008.SGD","LU1720050803.USD","LU2097828631.EUR","LU2097828805.USD","LU0634319403.HKD","LU0235996351.USD","LU0327786744.USD","BK1589","01810","LU1880383366.USD","LU1868838027.USD","LU0561508036.HKD","81810","LU2087589342.USD","SG9999003461.SGD","LU1981816686.USD","XIACY","LU1282648689.USD","MIUmain","LU1813983027.USD","LU0164880469.USD","LU0417516902.SGD","LU0499858602.USD","LU0348827113.USD","LU1303224171.USD","BK1615","LU2097828474.EUR","BK1506","LU0348816934.USD","LU0499858438.USD","BK1193"],"gpt_icon":0},{"id":"2540780236","title":"Innovent Biologics Announces Groundbreaking Phase 2 Trial of IBI363 for Treatment-Resistant Melanoma at ASCO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540780236","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540780236?lang=en_us&edition=fundamental","pubTime":"2025-06-01 09:39","pubTimestamp":1748741995,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc. has announced updated data from its Phase 1 and Phase 2 clinical studies on IBI363, a first-in-class PD-1/IL-2α-bias bispecific antibody fusion protein, at the 2025 American Society of Clinical Oncology  Annual Meeting. This study focuses on patients with advanced malignant melanoma, particularly the acral and mucosal subtypes, which are typically resistant to treatment. The research has shown promising results in these hard-to-treat \"cold\" tumors. Innovent Biologics is also conducting a pivotal Phase 2 registrational trial comparing IBI363 monotherapy to pembrolizumab in patients with unresectable, locally advanced, or metastatic mucosal and acral melanoma. The trial aims to enroll 180 patients and will evaluate progression-free survival as the primary endpoint. IBI363 was generally well tolerated, with manageable safety profiles, and no new safety risks were identified.Disclaimer: This news brief was created by Public Technologies  using generative artificial ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nNDL8gJRqs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","01911","01801","BK1583","LU2328871848.SGD","BK1161","LU1969619763.USD","LU2488822045.USD","BK1147"],"gpt_icon":0},{"id":"2540474780","title":"Asco 2025 Oral Presentation: Innovent Biologics Announces Updated Data of Ibi363 (First-in-Class Pd-1/Il-2Α -Bias Bispecific Antibody Fusion Protein) From Phase 1 and 2 Clinical Studies on Immunotherapy-Treated Advanced Malignant Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2540474780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540474780?lang=en_us&edition=fundamental","pubTime":"2025-06-01 09:39","pubTimestamp":1748741981,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nTUA3V3C3R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","BK1583","LU2328871848.SGD","BK1161","LU1969619763.USD","LU2488822045.USD","01801"],"gpt_icon":0},{"id":"2540780418","title":"Zeekr Group Reports 15.2% Year-Over-Year Growth with Over 46,000 Vehicles Delivered in May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2540780418","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540780418?lang=en_us&edition=fundamental","pubTime":"2025-06-01 09:30","pubTimestamp":1748741424,"startTime":"0","endTime":"0","summary":"Zeekr Intelligent Technology Holding Limited, a prominent player in the premium new energy vehicle sector, recently disclosed its delivery figures for May 2025. The company reported a total delivery of 46,538 vehicles across its Zeekr and Lynk & Co brands, marking a significant year-over-year growth of 15.2% and a month-over-month increase of 12.6%. This achievement underscores the strong support from its nearly 1.95 million users. Specifically, the Zeekr brand accounted for 18,908 of the deliveries, while Lynk & Co contributed with 27,630 vehicles.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zeekr Intelligent Technology Holding Ltd. published the original content used to generate this news brief via PR Newswire  on June 01, 2025, a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250601:nNDL3k8D8Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Zeekr Group Reports 15.2% Year-Over-Year Growth with Over 46,000 Vehicles Delivered in May 2025","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002828.SGD","LU1282651048.USD","BK1521","LU1861214812.USD","IE00B0JY6N72.USD","LU1861219969.SGD","BK1539","IE00BZ08YS42.EUR","BK1589","BK1119","IE00BZ08YT58.USD","LU2360107325.USD","LU0315179316.USD","LU1282651121.HKD","BK4099","LU1224444064.USD","ZK","80175","LU0293314216.USD","IE00BZ08YR35.GBP","EVS.SI","GELYY"],"gpt_icon":1},{"id":"2539748222","title":"BRIEF-Hansoh Pharmaceutical Says Third Biologics License Application Of Xinyue (Inebilizumab Injection) Accepted By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2539748222","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539748222?lang=en_us&edition=fundamental","pubTime":"2025-05-31 01:31","pubTimestamp":1748626268,"startTime":"0","endTime":"0","summary":"BRIEF-Hansoh Pharmaceutical Says Third Biologics License Application Of Xinyue  Accepted By NMPAMay 30  - Hansoh Pharmaceutical Group Company Ltd 3692.HK:THIRD BIOLOGICS LICENSE APPLICATION OF XINYUE  WAS ACCEPTED BY NMPAFurther company coverage: 3692.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nFWN3S203N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1589","BK1583"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":146,"code":"91000000","status":"200"}]}}